AstraZeneca

!Vive Tu Vida! Get Up! Get Moving! Third Annual Houston Family Fitness Celebration Announced.
Obesity, Fitness & Wellness Week; 11/21/2009; 635 words; ...for Hispanic Health. "We are grateful to our national sponsors for their support of these family health events. We thank AstraZeneca for helping us make heart health information available, Univision Communications for working to get the word out about the...

MAP Pharmaceuticals Reports Third Quarter of 2009 Financial Results.(Financial report)
Pediatrics Week; 11/21/2009; 1478 words; ...recognized upon the termination of the AstraZeneca AB license agreement in the third quarter...Pharmaceuticals' license agreement with AstraZeneca. On July 8, 2009, the company received notice from AstraZeneca of the termination of the license agreement...

New cancer study results from National Cancer Institute described.
Blood Weekly; 11/19/2009; 824 words; ...tumorigenesis. Small molecule inhibitors, such as Cephalon's CEP-701, are in phase 1 and 2 clinical trials, and a series of AstraZeneca Trk inhibitors are poised to enter the clinic. As monotherapy, inhibitors may be effective only in tumors with activating...

Zyngenia, Inc. Raises $10 Million in Series a Funding.
Gene Therapy Weekly; 11/19/2009; 1330 words; ...Scripps Translational Science Institute. Prior to joining NEA, he was President and CEO of MedImmune, which was acquired by AstraZeneca for $15.6 billion in 2007. During his 16 years at MedImmune, it grew from a small biotechnology company into one of...

Piedmont Triad, N.C., biotech news/Targacept Awarded Grant from Michael J. Fox Foundation to Conduct Research in the Treatment of Side Effects of Parkinsons Disease Therapy.
Biotech Week; 11/18/2009; 1457 words; ...Targacept also has a cognition-focused collaboration with AstraZeneca and a strategic alliance with GlaxoSmithKline. Targacept...linnmich@comcast.net Keywords: ADHD, Alzheimer Disease, AstraZeneca, Attention Deficit Hyperactivity Disorder, Behavior, Biopharmaceuticals...